RET-IN-17

发表于由

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白，专注于信号通路和疾病研究领域。

RET-IN-17 

RET-IN-17 是一种有效的 RET 抑制剂。RET-IN-17 具有研究与 IBS 和其他胃肠道疾病相关的疼痛以及研究具有组成性 RET 激酶活性的癌症的潜力 (摘自专利 WO2016038552A1，化合物 1)。

RET-IN-17

RET-IN-17 Chemical Structure

CAS No. : 1885880-08-9

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

RET-IN-17 is a potent inhibitor of RET. RET-IN-17 has the potential for the research of pain associated with IBS and other gastrointestinal disorders and for the research of cancers with constitutive RET kinase activity (extracted from patent WO2016038552A1, compound 1)[1].

分子量

548.53

Formula

C27H28F4N4O4
CAS 号

1885880-08-9
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献

  • [1]. Michael P. Demartino, et al. Pyridone derivatives as rearranged during transfection (ret) kinase inhibitors. Patent WO2016038552A1.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务